David W. Dodick, MD
Advertisement
Director, Concussion and Headache Programs, Mayo Clinic; Chair, American Brain Foundation, IHS-Global Patient Advocacy Coalition
Articles by David W. Dodick, MD
Here: highlights from a systematic review that these authors view as a substantial step forward in establishing an evidence-based approach to migraine treatment in the acute care setting.
Advertisement
Latest Updated Articles
Therapies in Development for Acute MigrainePublished: October 30th 2020 | Updated:
Gepants for Acute Migraine: Safety & Efficacy DataPublished: October 30th 2020 | Updated:
Treating Acute Migraine in the Community SettingPublished: October 30th 2020 | Updated:
Advances in the Treatment of Acute MigrainePublished: October 30th 2020 | Updated:
Real-World Experience With Gepants for Acute MigrainePublished: October 30th 2020 | Updated:
Ubrogepant: Treatment for Acute MigrainePublished: October 30th 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
3
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
4
CD40L Inhibitor Frexalimab Enters Phase 3 FREXITE Trial of Non-Relapsing Secondary Progressive Multiple Sclerosis
5